Intellectual Property

  • July 27, 2026

    Google Can't Get 2nd Try At Eliminating Network-1 Patent

    A New York federal judge has denied Google's request for a second attempt at invalidating a patent asserted by a patent licensing company, rejecting its arguments that a Federal Circuit decision from last month made another try necessary.

  • July 27, 2026

    Yale, Biohaven Win $4M In Biotech Trade Secret Trial

    A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.

  • July 27, 2026

    Samsung Owes $92.3M After Judge Boosts Media IP Award

    A Texas federal judge has heaped $13.8 million in prejudgment interest on top of a $78.5 million jury award owed by Samsung after it was found to infringe a pair of patents covering automatic content recognition technology for commercial advertising.

  • July 27, 2026

    AbbVie Seeks Block On Alkem Generic Constipation Drug

    AbbVie Inc. and collaborator Ironwood Pharmaceuticals urged a New Jersey federal court to bar India-based generic-drug maker Alkem Laboratories from selling generic versions of their branded constipation drug while associated patents are active, arguing Alkem would violate patent law by doing so.

  • July 27, 2026

    Ad Patent Claims Against Hulu Are Invalid, Judge Says

    A California federal judge has cleared Hulu from a lawsuit accusing it of infringing patents covering ways to deliver content and advertising through streaming, after finding the patents themselves were invalid to begin with.

  • July 27, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week tackled disputes involving restrictive covenants, corporate governance, trade secrets, real estate investments, receiverships, and books and records demands.

  • July 27, 2026

    NASCAR Says It's 'Overwhelmed' By 'Mass Counterfeiting'

    NASCAR is cracking down on counterfeit merchandise in a federal lawsuit filed Monday in North Carolina that seeks to block an alleged network of foreign retailers from selling knockoff clothing and collectibles through online marketplaces, social media platforms and search engines like Google.

  • July 27, 2026

    Stewart Leaving USPTO This Week For Private Sector Job

    Deputy U.S. Patent and Trademark Office Director Coke Morgan Stewart will leave the office this week to return to the private sector, she told the USPTO executive staff Monday in a message obtained by Law360.

  • July 27, 2026

    End Defamation Claim Against Baker Botts Atty, Court Advised

    A Florida federal magistrate judge has recommended that a defamation claim against a Baker Botts LLP patent attorney be tossed, saying an inventor hasn't shown that the lawyer's comments to a reporter at issue in the case were defamatory.

  • July 27, 2026

    Arnold & Porter Hires King & Spalding ITC-Focused Atty

    Arnold & Porter Kaye Scholer LLP has hired a King & Spalding LLP partner in Washington, D.C., who will continue his intellectual property work focused on the cross-border aspects of technology and life sciences disputes, the firm announced Monday.

  • July 24, 2026

    Phillips 66 Inks Deal To End Patent Case Revived By Fed. Circ.

    Phillips 66 has settled allegations it infringed Magema Technology's oil refinery patents, reaching a deal nearly a year after the Federal Circuit held that ordered a new trial in the yearslong battle.

  • July 24, 2026

    IP Cases In The Spotlight As ITC Adds 5 New Commissioners

    The Senate's confirmation of five new commissioners at the International Trade Commission, including two who were staffers on the intellectual property committees in Congress, could lead to a greater focus on IP cases at the commission and efforts to speed them up, attorneys say.

  • July 24, 2026

    Big Fish Can't Pursue Apple Store Takedown, Dev Says

    An Armenian game developer accused of withholding source code belonging to Big Fish Games urged a Washington federal judge Friday to block the company's attempt to have games removed from the Apple Store.

  • July 24, 2026

    Full Fed. Circ. Urged To Reconsider Pfizer's Paxlovid IP Win

    Enanta Pharmaceuticals is asking the Federal Circuit to rethink its June refusal to revive a patent it had asserted against Pfizer over its COVID-19 treatment Paxlovid, saying the court acted beyond its authority.

  • July 24, 2026

    Daily Beast Sued Over Image Of CEO In Viral Coldplay Incident

    A photographer sued the Daily Beast in New York federal court on Friday for using his image of Andy Byron, the former CEO of software company Astronomer who was caught in a viral "kiss cam" incident at a Coldplay concert.

  • July 24, 2026

    Finch Therapeutics Can Seek Ch. 11 Plan Votes

    A Delaware bankruptcy judge on Friday conditionally approved the disclosure statement for microbiome treatment developer Finch Therapeutics' Chapter 11 plan, allowing it to solicit creditor votes.

  • July 24, 2026

    Yale Age Test, Allergy Death, Wine Royalties: A Midyear Report

    In the second half of 2026, Connecticut courts are being called upon to decide closely watched issues such as whether the state's largest hospital group violated federal disability and age discrimination laws when requiring providers over age 70 to undergo mandatory cognitive tests.

  • July 24, 2026

    NCAA Urges Judge To Not Let Athletes 'Rewrite' NIL Deal

    The NCAA has opposed an effort to relax the oversight of college athletes' third-party branding deals, telling a California federal judge that the players are looking to "rewrite" a historic antitrust settlement. 

  • July 24, 2026

    Fed. Circ. Backs Invalidating More PTAB Railcar Patent Claims

    The Federal Circuit on Friday backed another Patent Trial and Appeal Board decision that claims in an Amsted Rail Co. Inc. patent on monitoring trains were invalid, less than two months after affirming similar board decisions on two other patents.

  • July 24, 2026

    Novo Asks NJ Judge To Stop Lilly's 'Deceptive' GLP-1 Ads

    Novo Nordisk Inc. asked a New Jersey federal court Friday to block rival Eli Lilly & Co. from running ads allegedly comparing their respective GLP-1 drugs using "outdated" clinical trials and "false superiority messages," arguing the ads are damaging its reputation and misleading consumers.

  • July 24, 2026

    Spotify 'Slow-Rolled' Discovery In Audiobook Case, Court Told

    A nonprofit royalties distribution group said Spotify has "slow-rolled" discovery in a case challenging its new method for calculating artist royalties and asked a Manhattan federal judge to order the streaming giant to produce key documents.

  • July 24, 2026

    Vicor Rival Alleges Trade Secret Misuse In WDTX Suit

    Semiconductor company Delta Electronics accused competitor Vicor Corp. of disclosing its confidential trade secrets as part of a campaign of aggressively pursuing patent allegations against rivals in order to get licensing revenue.

  • July 24, 2026

    5 TM Cases & 1 Strategy To Watch In 2026's Second Half

    The U.S. Supreme Court will weigh a trademark dispute that asks whether juries or judges should decide if a mark is inherently strong, while courts will continue testing the impact of the justices' Jack Daniel's decision over a key test in trademark infringement cases. Here are Law360's picks for trademark cases to watch for the rest of the year.

  • July 24, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen financial advice firm Smith Square Partners sue ailing social housing company Home REIT, Pogust Goodhead hit with a contract claim by one of its investors, and Entain faced with its latest claim in expanding litigation linked to alleged bribery at its former Turkish business. Here, Law360 looks at these and other new claims in the U.K.

  • July 24, 2026

    Sensodyne, Aquafresh Makers Sue Over Rival's 'Sensio' TMs

    The companies behind Sensodyne and Aquafresh have sued a beauty and personal care retailer, alleging its "Sensio" toothpaste range and "Triple Protect" oral care products could cause consumers to confuse them with their best-selling brands.

Expert Analysis

  • Quantum Readiness May Paradoxically Raise Contractor Risk

    Author Photo

    The organizations best positioned for the cryptographic system migration deadlines and other requirements under President Donald Trump’s recent quantum executive orders will be those able to inventory their cryptographic dependencies while protecting their vulnerability road map from adversaries, says Jesse Lemon at The Beckage Firm.

  • Why Biotech Cos. Need Litigation Plans Before Bad News

    Author Photo

    Biotech companies should take proactive steps to respond to the growing trend of securities litigation filed against them, due to the inherently uncertain nature of their business models and heightened scrutiny of clinical trial disclosures, regulatory communications and investor-facing statements, says Wesley Horton at FBFK.

  • 10 Years, 150 Cases: The Rise And Fall Of Post-Halo Damages

    Author Photo

    When the U.S. Supreme Court decided Halo v. Pulse in 2016, patent practitioners predicted that enhanced damages would become easier to win, but analysis of every contested district court ruling on a motion for enhanced damages in the last 10 years shows that courts have shown increasing restraint, say attorneys at Reichman Jorgensen.

  • Trump EOs Pair Quantum Push With Cyber Defense Overhaul

    Author Photo

    Two recent executive orders that mark a significant federal commitment to both advancing and defending against quantum technology create potential opportunities for companies in the quantum, AI and technology sectors and pose future compliance obligations contractors should begin considering now, say attorneys at King & Spalding.

  • Series

    Choral Singing Makes Me A Better Lawyer

    Author Photo

    Singing in the New York City Bar Chorus — a hobby partly inspired by the late U.S. District Judge Richard Owen, who infused my clerkship year with opera music — has improved my legal career by refining my abilities to listen, exude confidence and develop emotional intelligence, says Bonnie Baker at Friedman Kaplan.

  • Attorney Mental Health Is An Ethical Obligation In The AI Era

    Author Photo

    As attorneys cope with the increasing unpredictability that artificial intelligence and constant policy changes have created, particularly in practice areas where they carry the emotional weight of clients’ most consequential life events, otherwise soft discussions about self-care are a matter of professional competence, says attorney Jack Jrada.

  • The Case For Using Final-Offer Damages Forms In IP Suits

    Author Photo

    Recent Federal Circuit decisions, such as Ollnova v. Ecobee, that scrutinize verdict forms in patent infringement disputes potentially render the final-offer damages selection procedure more attractive, though it should not be seen as a replacement for patent damages doctrine, says Brandon Theiss at Addy Hart.

  • 3 Litigation Strategies To Stay Ahead Of Bad Facts

    Author Photo

    A case with damaging facts can still be won if, instead of avoiding the facts, attorneys proactively address them by carefully selecting a strategy of confronting, containing or reframing, says Allison Rocker at Baker McKenzie.

  • Key Tips For Patenting Antibody-Drug Conjugate Inventions

    Author Photo

    Recent decisions highlight the significant challenges that can arise when patenting antibody-drug conjugates, which require strategic considerations for satisfying heightened written description and enablement requirements, says Xiaoban Xin at FisherBroyles.

  • $885M IBS Drug Verdict Tests Pay-For-Delay Limits

    Author Photo

    The outcome in the Amitiza Antitrust Litigation is significant because it is the first jury trial win for private antitrust plaintiffs in a suit challenging a patent settlement reverse payment since the U.S. Supreme Court adopted the rule-of-reason legal framework in 2013, offering a blueprint for pay-for-delay claims, say attorneys at Katten.

  • Series

    Power To The Paralegals: Burnout As A Structural Problem

    Author Photo

    Law firm leadership can best retain their paralegals not by encouraging self-care, but by seeking top-down structural solutions for the quiet proliferation of responsibilities and the vicarious exposure to client trauma that particularly drive burnout in this vital role, says Erika Sneeringer at Brockstedt Mandalas.

  • Fed. Circ. In May: Being Precise About 'About'

    Author Photo

    The Federal Circuit's decision in Enviro Tech v. Safe Foods last month illustrates the danger in attempting to expand claim scope with words of approximation, potentially causing claims to be invalid for lack of definiteness, say attorneys at Knobbe Martens.

  • Ill. Law Firm MSO Bill Clashes With Court Power, Ethics Rules

    Author Photo

    An Illinois bill prohibiting law firms from certain business arrangements with management service organizations, sent to the governor for signature last week, encroaches upon the courts' constitutional powers and goes beyond the Illinois Rules of Professional Conduct in regulating investment in law-related services, says Matthew O’Hara at Smith Gambrell.

  • The Future Of WDTX Patent Litigation After Judge Albright

    Author Photo

    With U.S. District Judge Christopher Wolfe set to take over much of Judge Alan Albright's patent infringement docket in the Western District of Texas later this year, attorneys should prepare for potential differences in Judge Wolfe's approach to the court's high volume of patent litigation, say attorneys at Sidley Austin.

  • Constructing AI Compliance Plans As State Laws Diverge

    Author Photo

    With Colorado, Connecticut and the federal government recently announcing wildly different approaches to artificial intelligence regulation, creating a workable compliance program means addressing overlapping obligations using shared systems rather than separate silos, say attorneys at Ogletree.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.